Mar 12, 2018 - Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2017 Earnings Conference Call March 12, 2018, 17:00 ET Executives Jason Shandell - President William Peters - CFO Yongfeng Zhang - CEO Analysts David A
Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Feb 28, 2018 - Mallinckrodt PLC (MNK) shares rose more than 15% in the last trading session, amid huge volumes.
Feb 21, 2018 - Penumbra (PEN) expects to gain from solid performance by neuro and peripheral vascular arms in Q4. Strong growth across all geographies is likely to drive the top line.
Feb 21, 2018 - Consistent focus on Subscription Services is likely to drive Veeva Systems (VEEV) in Q4.
Feb 21, 2018 - Strong product portfolio and a unique direct-to-consumer business model are expected to drive Inogen (INGN) in Q4.
Feb 20, 2018 - Express Scripts (ESRX) expects Q4 results to show earnings growth on strength in PBM segment.
Feb 13, 2018 - PerkinElmer (PKI) rides on synergies from the acquisition of EUROIMMUN and broadened product base.
Feb 12, 2018 - Henry Schein (HSIC) likely to gain on strength across all business segments in Q4.
Feb 12, 2018 - Ecolab's (ECL) strong segmental sales and acquisition-driven strategies are likely to drive fourth-quarter results.